Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection or get a serious infection from them.
Patient Assistance Program
The Novo Nordisk Patient Assistance Program (PAP) is based on our commitment to our patients. The Patient Assistance Program provides medicine at no cost to those who qualify.
Patients who are approved for the PAP may qualify to receive free medicine from Novo Nordisk. There is no registration charge or monthly fee for participating.
Click here for a list of our Novo Nordisk products covered by the PAP.
Who can participate in the Patient Assistance Program?
To be eligible for this program in 2026, you must:
- Be a US citizen or legal resident
- Have a total household income that qualifies. Visit the NeedyMeds website, which lists the current Federal Poverty Level (FPL) guidelines
- Have Medicare or no insurance (Note: If you have private or commercial insurance, you are not eligible for the PAP)
- Not be enrolled in or qualify for any other federal, state, or government program such as Medicaid, Medicare Low Income Subsidy (LIS, or Extra Help Program), or Veterans Affairs (VA) Benefits
- If you are eligible for Medicaid or Medicare LIS, you must submit a copy of your denial letter with your application.
For patients on Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg
For patients on Ozempic® pen
- Most Medicare Part D plans cover Ozempic®. Medicare beneficiaries with Part D coverage will no longer be eligible to receive Ozempic® through the Patient Assistance Program.
- Next Steps:
- Plan your spending: You also have the option of spreading your prescription costs throughout the plan year by enrolling in the Medicare Prescription Payment Plan (MPPP). To learn more about this program, click here.
- Uninsured patients will still have access to Ozempic® through the Patient Assistance Program; however, their total household income must be at or below 200% of the federal poverty level.
- Resources:
- Visit NeedyMeds website, which lists the current FPL guidelines, for more information.
For Medicare patients on Novo Nordisk insulins
For Medicare patients on Novo Nordisk insulins
- Total household income must be at or below 400% of the federal poverty level.
- Medicare beneficiaries with a total household income below 150% of the federal poverty level must provide proof of denial for Part D Extra Help to qualify.
- Next Steps:
- For more information on how to apply for the Extra Help Program, please click here. If you will be a Medicare patient in 2026 and meet eligibility requirements for PAP, please start your application here.
- Novo Nordisk has other programs to help make insulin affordable. Explore your options.
- Medicare resources designed for you
For uninsured patients on all products
For uninsured patients on all products
- Total household income must be at or below 200% of the federal poverty level for Ozempic®.
- For all other medications, total household income must be at or below 400% of the federal poverty level.
- Uninsured patients must provide proof of a Medicaid denial prior to enrollment in the PAP if the patient’s total household income meets their state federal poverty limit thresholds. For more information about your state’s Medicaid program, you can click here. You can also visit the NeedyMeds website, which lists the current FPL guidelines, for more information.
- Next Steps:
- For uninsured insulin patients, Novo Nordisk has other programs to help make insulin more affordable. Click here for insulin affordability options.
A special note about your medicine
Some medicines will no longer be a part of the Patient Assistance Program for 2026. Please click here to see a list of Novo Nordisk medicines that are still covered by the program.
Fill out the application online
The Spanish application is coming soon.
Note: If you are eligible for Medicaid or Medicare LIS, you must submit a copy of your denial letter with your application.
STEP 1: Patient application portion
Click here to submit the patient portion of your application. Please note you’ll need your health care provider’s email address for them to complete their portion of the application.
Please let your HCP know that they will receive a secure link via email to complete their portion of the application.
STEP 2: Additional documents
During application, you may be prompted to provide additional documentation, such as Proof of Income, Medicaid LIS Denial, or Government ID.
STEP 3: Approval and delivery
If your application is approved, we will contact your doctor for a prescription. Please expect a call from Neovance™ Specialty Pharmacy at 1‑800‑488‑5908 to schedule delivery of your medicine to your home.
Product availability subject to change without notice.
Novo Nordisk reserves the right to modify or cancel this program at any time without notice.
Questions? See the frequently asked questions below or call Novo Nordisk toll-free at 1‑866‑310‑7549.
Online enrollment details
Why is enrollment moving to online only?
Online enrollment allows applications to be reviewed faster and more accurately, by eliminating delays caused by incomplete or unreadable fax submissions. This means quicker decisions and fewer follow-ups for patients.
What if I don’t have access to a computer or the internet?
The application can be completed on either a computer or a smartphone, so many patients use their mobile device. If that’s not an option, your healthcare provider’s office can assist, and we are also here to help guide you through the process.
Is my information safe online?
Yes. The online enrollment system uses secure, HIPAA-compliant technology designed to protect your personal and health information.
Do I need to reapply if I’m already enrolled?
No immediate action is required for current patients unless you are notified. However, any future updates, renewals, or new applications will need to be completed online.
If approved, how long am I enrolled in the program?
Uninsured patients are enrolled for 12 months. Medicare patients are enrolled for a calendar year.
I have Medicare Part D coverage. Do I need to spend $1000 in out-of-pocket prescription costs before I am able to apply to the program?
No, we no longer require that Medicare Part D patients spend $1000 out-of-pocket to be eligible for the program.
Application process and approval
How long does it take to process an application?
If an application is submitted with all supporting documentation and all required fields completed, it will be processed within 2 business days. Any missing or incomplete information may cause a delay.
How will I know if I have been approved?
If approved, patients will get a letter in the mail. If they choose automated phone alerts on the application, they will also get an automated phone or text message.
If I have been approved, how long does it take to receive my medication?
Once the patient is approved, they’ll get their medicine shipped to their home within 5 business days. The patient should expect a call from Neovance™ Specialty Pharmacy at 1‑800‑488‑5908 to set up the delivery.
Direct-to-patient shipment
Where will my medicine be shipped now?
Medicine will be shipped directly to your home or another address of your choosing. This change allows your medicine to be delivered faster and more reliably by removing extra handoffs that can sometimes cause delays. You should expect a call from Neovance™ Specialty Pharmacy at 1‑800‑488‑5908 to set up the delivery.
Why is my medication no longer being sent to my doctor’s office?
Shipping directly to patients helps prevent misplaced or delayed packages and allows your care team to focus on your treatment instead of medication logistics. This approach is common across patient assistance programs and helps streamline access.
When will the pharmacy contact me to arrange shipping?
After your enrollment is approved and your prescription is received, the pharmacy will initiate shipment without delay. If you have opted in to text messages, you will receive a text notification to confirm shipment details. This helps ensure your medication is sent to the right place at the right time without unnecessary waiting.
How will I know when my medication ships?
If you’ve opted in to text messages, you’ll receive a text once your medication ships along with a tracking number. While text messaging is optional, it is the most efficient way to receive timely updates regarding your shipment.
Can you ship my medication directly to a local pharmacy?
Unfortunately, we are currently not able to ship directly to a pharmacy.
Do I have to pay for shipping?
No. Shipping costs remain fully covered by the Patient Assistance Program.
Change of doctor or address
What should I do if I have switched doctors?
Please contact us at 1-866-310-7549 so we can provide additional direction.
What if my address changes or I need to update where my medication is sent?
Address updates can be made through the enrollment system or by contacting Neovance™ Specialty Pharmacy at 1‑800‑488‑5908.
What should I do if my doctor has moved?
Please contact us at 1-866-310-7549 so we can update your records.
PAP reapplication
Do I have to reapply to the program when my enrollment ends?
Yes. Patients will need to submit a new application and supporting documentation when their enrollment ends if they'd like to be considered for continued support.
If my enrollment is ending, how soon can I reapply to the program?
Patients may submit a new application 30 days prior to the end of their enrollment. Medicare Part D patients may apply after October 15th of the current year to enroll for the following year.
Program information
Medicare Part D
Those with Medicare Part D coverage may apply for next year’s PAP enrollment after October 15, 2026.
Find helpful resources
Need help navigating insurance?
We can make health insurance easier to understand. From copays to deductibles, we explain common terms and tell you how health insurance works. You’ll also see tips to get the most out of your plan, or find a new one.
Resources and education
Find inspiration and motivation for staying active, eating healthy, and building up your knowledge with resources and education from NovoCare®.